首页|期刊导航|中国实验方剂学杂志|中医药调控相关信号通路干预胰腺癌研究进展

中医药调控相关信号通路干预胰腺癌研究进展OA

Regulation of Relevant Signaling Pathways by Traditional Chinese Medicine in Intervention of Pancreatic Cancer:A Review

中文摘要英文摘要

胰腺癌是一种恶性程度高、治疗预后极差的消化系统实体肿瘤,发病率低但死亡率极高.近年来全球的确诊患者持续增加,使得胰腺癌已成为全球第6大癌症死因.目前临床多采用手术与化疗手段抑制肿瘤,然而,这些方案存在着疗效欠佳,术后高复发性以及不良反应严重等问题.因此,寻找安全有效的治疗手段是医学界亟待解决的一项难题.近年来,中医药干预胰腺癌的研究日益增多,多项研究表明单味中药、中药复方及其来源的单体化合物可通过多个作用靶点调控肿瘤细胞信号通路水平,通过抑制癌细胞增殖、促进细胞凋亡、抑制肿瘤血管生成、降低癌细胞侵袭迁移能力、调节细胞周期及肿瘤微环境等抑制胰腺癌的发生和发展,此外,中医药还具有显著提高化疗药的抑癌效果、不良反应少等优势.然而,目前中医药干预胰腺癌的具体作用机制尚未完全明确,其通过调控胰腺癌细胞中的磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)/哺乳动物雷帕霉素靶蛋白(mTOR)、Wnt/β-连环蛋白(β-catenin)、核转录因子-κB(NF-κB)、切口蛋白(Notch)、刺猬蛋白(Hedgehog)等经典信号通路抑制胰腺癌的研究仍需大量研究进一步验证.因此,该文对近年来中医药通过相关信号通路干预胰腺癌的国内外研究进行综述,归纳总结中医药在胰腺癌的治疗中可能的作用机制,为后续相关研究提供参考.

Pancreatic cancer is a highly malignant solid tumor of the digestive system with extremely poor treatment prognosis.Although its incidence rate is low,its mortality rate is extremely high.In recent years,the number of diagnosed cases worldwide has continued to rise,making pancreatic cancer the sixth leading cause of cancer-related deaths globally.Currently,clinical treatment primarily relies on operation and chemotherapy to suppress tumors.However,these approaches face challenges such as suboptimal efficacy,high postoperative recurrence rates,and severe adverse reactions.Therefore,identifying safe and effective treatment modalities remains a pressing challenge for the medical community.In recent years,research on traditional Chinese medicine(TCM)interventions for pancreatic cancer has increased significantly.Multiple studies have shown that single-herb TCM,TCM formulas,and their derived single compounds can regulate the levels of tumor cell signaling pathways through multiple action targets.They inhibit the development and progression of pancreatic cancer by inhibiting cancer cell proliferation,promoting cell apoptosis,inhibiting tumor angiogenesis,reducing cancer cell invasion and migration capabilities,regulating the cell cycle,and modulating the tumor microenvironment.Additionally,TCM has the advantages of significantly enhancing the anticancer efficacy of chemotherapy drugs and causing fewer adverse reactions.However,the specific action mechanisms by which TCM intervenes in pancreatic cancer remain unclear.Further extensive research is still needed to validate the role of regulating classical signaling pathways such as phosphoinositide 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR),Wnt/β-catenin,nuclear transcription factor-κB(NF-κB),notch,and hedgehog in the treatment of pancreatic cancer.Therefore,this paper reviewed Chinese and international studies on TCM intervention in pancreatic cancer through relevant signaling pathways in recent years,summarized the potential action mechanisms of TCM in the treatment of pancreatic cancer,and provided references for related research in the future.

赵全友;赵聪慧;张雨;付依萍;刘玉婷;王笑冉;李占占;苗明三;白莉

河南中医药大学药学院,郑州 450046河南中医药大学药学院,郑州 450046河南中医药大学中医药科学院豫药全产业链研发河南省协同创新中心,郑州 450046河南中医药大学中医药科学院豫药全产业链研发河南省协同创新中心,郑州 450046河南中医药大学药学院,郑州 450046河南中医药大学中医药科学院豫药全产业链研发河南省协同创新中心,郑州 450046河南中医药大学中医药科学院豫药全产业链研发河南省协同创新中心,郑州 450046河南中医药大学中医药科学院豫药全产业链研发河南省协同创新中心,郑州 450046河南中医药大学药学院,郑州 450046

医药卫生

胰腺癌中医药信号通路研究进展综述

pancreatic cancertraditional Chinese medicinesignaling pathwayresearch progressreview

《中国实验方剂学杂志》 2026 (5)

280-289,10

国家自然科学基金面上项目(82274119)河南省重大科技专项(221100310400)河南省重点研发专项(251111310400)河南省中医药科学研究重大专项(2024ZYZD15)河南省高等学校重点科研项目(25CY021)河南省重大公益专项(201300310100)河南省重点研发专项计划项目(241111311500)河南省中原学者工作站项目(234400510021),河南省科技攻关项目(252102310532)

10.13422/j.cnki.syfjx.20252004

评论